Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PALVELLA THERAPEUTICS, INC.”

9 pharma patents match "PALVELLA THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "PALVELLA THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “PALVELLA THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12329748

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  2. US 12268673

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  3. US 11679101

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  4. US 11617742

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted
  5. US 11135204

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  6. US 11000513

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  7. US 10722499

    Anyhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  8. US 10172789

    Compositions for transdermal delivery of mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  9. US 9855252

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted